Evidence Library

Showing 10 of 401 results.
Lainie Rutkow, JD, PhD •
Johns Hopkins University Bloomberg School of Public Health
Caleb Alexander, MD, MS •
Johns Hopkins University Bloomberg School of Public Health

The study finds Florida’s efforts to prevent inappropriate use of painkillers are showing reductions among prescribers and patients who had the highest prescribing and usage rates.

 
Barbara Dennison, MD •
Health Research Inc./New York State Department of Health

The study reviewed policies from all 129 NY hospitals providing maternity care services. In 2009, none were fully compliant with WHO recommendations, but by 2013, 97, or 75 percent of the hospitals had compliant hospital breastfeeding policies. And as of April 2014, all 129 hospitals in New York had a fully compliant, approved, written breastfeeding policy in place.

 

This Knowledge Asset includes information about the impacts of bullying; the public health framework for anti-bullying laws; the language and content of these laws; and current evaluation studies on the implementation and effectiveness of anti-bullying laws.

 
Corey Davis, JD, MSPH •
University of North Carolina at Chapel Hill

Drug overdose is the leading cause of injury-related death in the United States, killing more people every year than car crashes. While naloxone has been used in hospitals and ambulances for decades, the rising tide of overdose deaths has resulted in calls to make it more available to laypeople and first responders.

 
Corey Davis, JD, MSPH •
University of North Carolina at Chapel Hill

Researchers reviewed 47 prescription monitoring program (PMP) websites for overdose content. They found that most PMPs did not address overdose or related terms in available materials and few state PMPs project overdose-specific messaging or provider tools for prevention.

 
Ameet Sarpatwari, JD, PhD •
Brigham and Women’s Hospital Inc.
Aaron Kesselheim, MD, JD, MPH •
Brigham & Women’s Hospital

In a Perspective for the New England Journal of Medicine, Sarpatwari and Kesselheim discuss the future of follow-on biologics in the United States. Among other issues, the article discusses the impact that so-called carve-outs from state drug product selection laws will have on reducing the market penetration of interchangeable biologics.

 
Lainie Rutkow, JD, PhD •
Johns Hopkins University Bloomberg School of Public Health

A new study released on March 2, 2015, in Health Affairs reports that most primary care physicians are aware of prescription drug monitoring programs and have used the data in their practices, but do so only intermittently.

The study surveyed 420 physicians randomly identified through the American Medical Association’s Masterfile list. Of those physicians surveyed, 72 percent were aware of their state’s prescription drug monitoring program, and 53 percent reported that they had used the programs.

 
Kelly Thompson, JD •
Public Health Management Corporation/National Nurse-Led Care Consortium

This dataset presents information about the ability of non-physician providers to provide primary care though telehealth and be reimbursed for those services in all 50 states and Washington, DC.  

 

Pages